![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Chavez, Myra N.; Fuchs, Benedikt; Moellhoff, Nicholas; Hofmann, Daniel; Zhang, Lifang; Selao, Tiago Toscano; Giunta, Riccardo E.; Egana, Jose Tomas; Nickelsen, Joerg und Schenck, Thilo L.
(2021):
Use of photosynthetic transgenic cyanobacteria to promote lymphangiogenesis in scaffolds for dermal regeneration.
In: Acta Biomaterialia, Bd. 126: S. 132-143
Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2016):
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
In: Journal of Clinical Oncology, Bd. 34, Nr. 20:
2341-U66
Gluz, Oleg; Hofmann, Daniel; Würstlein, Rachel; Liedtke, Cornelia; Nitz, Ulrike und Harbeck, Nadia
(2013):
Genomic Profiling in Luminal Breast Cancer.
In: Breast Care, Nr. 6: S. 414-422
[PDF, 261kB]
Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E.; Schinkoethe, Timo; Staib, Peter und Harbeck, Nadia
(2013):
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
In: Trials
14:261
[PDF, 1MB]